Pharmacokinetic study of a combination chemo-endocrine treatment of paclitaxel and toremifene

被引：0
|
作者：
Saeki, T.
Okita, A.
Aogi, K.
Kakishita, T.
Okita, R.
Taira, N.
Takashima, S.
Fujita, K.
Nishikawa, K.
机构：
[1] Saitama Med Sch, Saitama, Japan
[2] Shikoku Canc Ctr, Matsuyama, Ehime, Japan
[3] Saitama Med Sch, Moroyama, Saitama, Japan
[4] Nippon Kayaku Co Ltd, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
13017
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Belinostat in Combination With Carboplatin and Paclitaxel (BelCaP) for Treatment of Bladder Cancer - A Pharmacokinetic Study of Exposure to Belinostat and Its Metabolites
    Jones, R. J.
    Tjornelund, J.
    Erichsen, K. D.
    Sengelov, L.
    De Bono, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S506 - S506
  • [32] Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer
    John R. Murren
    Kathleen Peccerillo
    Susan A. DiStasio
    Xin Li
    Janine J. Leffert
    Giuseppe Pizzorno
    Barbara A. Burtness
    Anne McKeon
    Yung chi Cheng
    Cancer Chemotherapy and Pharmacology, 2000, 46 : 43 - 50
  • [33] REDUCING CARCINOGENIC RISK IN A CELL CULTURE MODEL FOR CHEMO-ENDOCRINE RESISTANT BREAST COMEDO DUCTAL CARCINOMA IN SITU
    Telang, N.
    Katdare, M.
    CELLULAR ONCOLOGY, 2010, 32 (03) : 191 - 192
  • [34] Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer
    Murren, JR
    Peccerillo, K
    DiStasio, SA
    Li, X
    Leffert, JJ
    Pizzorno, G
    Burtness, BA
    McKeon, A
    Cheng, YC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (01) : 43 - 50
  • [35] RANDOMIZED TRIAL OF CHEMO-ENDOCRINE THERAPY, ENDOCRINE THERAPY, AND MASTECTOMY ALONE IN POSTMENOPAUSAL PATIENTS WITH OPERABLE BREAST-CANCER AND AXILLARY NODE METASTASIS
    GOLDHIRSCH, A
    LANCET, 1984, 1 (8389): : 1256 - 1260
  • [36] A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors
    Vlahovic, Gordana
    Karantza, Vassiliki
    Wang, Ding
    Cosgrove, David
    Rudersdorf, Nikita
    Yang, Jianning
    Xiong, Hao
    Busman, Todd
    Mabry, Mack
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (05) : 976 - 984
  • [37] A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors
    Gordana Vlahovic
    Vassiliki Karantza
    Ding Wang
    David Cosgrove
    Nikita Rudersdorf
    Jianning Yang
    Hao Xiong
    Todd Busman
    Mack Mabry
    Investigational New Drugs, 2014, 32 : 976 - 984
  • [38] Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer
    Ritsu Yamamoto
    Masanori Kaneuchi
    Masashi Nishiya
    Yukiharu Todo
    Mahito Takeda
    Kazuhira Okamoto
    Hiroaki Negishi
    Noriaki Sakuragi
    Seiichiro Fujimoto
    Takeshi Hirano
    Cancer Chemotherapy and Pharmacology, 2002, 50 : 137 - 142
  • [39] Clinical trial and pharmacokinetic study of combination paclitaxel and carboplatin in patients with epithelial ovarian cancer
    Yamamoto, R
    Kaneuchi, M
    Nishiya, M
    Todo, Y
    Takeda, M
    Okamoto, K
    Negishi, H
    Sakuragi, N
    Fujimoto, S
    Hirano, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 50 (02) : 137 - 142
  • [40] Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer A case report
    Maltoni, Roberta
    Palleschi, Michela
    Gallerani, Giulia
    Bravaccini, Sara
    Cecconetto, Lorenzo
    Melegari, Elisabetta
    Altini, Mattia
    Rocca, Andrea
    MEDICINE, 2020, 99 (24) : E20396
12345